BABA vs FRSX

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

FRSX exhibits a stable Piotroski F-Score of 5/9, but this is overshadowed by catastrophic operational performance and extreme valuation disconnects. While the company maintains a healthy current ratio (3.30) and low debt, its operating margin of -3788.61% and a Price-to-Book ratio of 52.05 indicate a company that is destroying equity at an unsustainable rate. With revenue shrinking by 21.8% YoY and a 5-year price collapse of 99.6%, the stock is a classic 'falling knife' despite a single analyst's bullish outlier rating.